The FDA still recommends prescribers monitor patients’ ANC levels according to the prescribing information. The Food and Drug Administration (FDA) has removed the risk evaluation and mitigation ...

Lithium and valproate are associated with a significantly lower risk for suicide in patients with schizophrenia or bipolar ...

A new, neuroplasticity-promoting drug closely related to LSD harnesses the psychedelic’s therapeutic power with reduced ...

Assisted Outpatient Treatment is involuntary, but it can help keep people struggling with psychosis out of more restrictive ...

A newer and innovative form of relational therapy is AVATAR Therapy. This approach works by “embodying” the voice through a digital avatar. The therapist then uses this avatar to reshape how the ...

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

Research highlights the potential for modifying the chemical structures of psychedelics to produce analogues with improved ...

Their findings show that the risk of blood cancer associated with the use of clozapine is very low, with an average increase of less than six cases per 10,000 persons using clozapine for one year.

A team at UC Davis has created a new drug called JRT that mimics LSD’s brain-healing effects without the hallucinogenic side ...